D933YC00001

Research code: D933YC00001
Research name: Randomised double-blind, placebo-controlled, multicentre phase III research evaluating durvalumab in consolidation therapy in patients with locally advanced inoperable non-small cell lung cancer (stage III) who have failed to progress after definitive platinum derivative-based chemotherapy (PACYFIC 5).
Indication: lung cancer
Principal researcher: Ewa Chmielowska, MD, PhD